MiNK Therapeutics, Inc. (INKT) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 10.02M | 13.85M | 14.53M | 2.01M | 3.58M | 4.99M | 6.58M | 9.47M | 6M | 3.6M | 6.47M | 11.05M | 15.52M | 20.4M | 24.46M | 30.33M | 35.48M | 39.63M | 878.55K | 4.2M |
| Cash & Short-Term Investments | 9.53M | 13.36B | 14.28M | 1.68M | 3.23M | 4.58M | 6.33M | 9.31M | 5.82M | 3.37M | 6.4M | 10.62M | 14.89M | 19.64M | 24.16M | 29.85M | 34.69M | 38.89M | 819.45K | 1.66M |
| Cash Only | 9.53M | 13.36B | 14.28M | 1.68M | 3.23M | 4.58M | 6.33M | 9.31M | 5.82M | 3.37M | 6.4M | 10.62M | 14.89M | 19.64M | 24.16M | 29.85M | 34.69M | 38.89M | 819.45K | 1.66M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23K | 35K | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 232.26K | -13.35B | 32 | 55.21K | 108.71K | 164.24K | 11.2K | 61.14K | 122.48K | 177.96K | 29.34K | 166.03K | 320.89K | 470.3K | 37.52K | 378.13K | 604.64K | 721.32K | 10.87K | 2.37M |
| Total Non-Current Assets | 354.52K | 390.87K | 429.34K | 473.21K | 687.5K | 732.93K | 799.52K | 849.96K | 894.99K | 953.98K | 991.46K | 1.06M | 1.07M | 1.07M | 803.13K | 787.54K | 665.21K | 606.59K | 3.2M | 552.48K |
| Property, Plant & Equipment | 354.52K | 390.87K | 429.34K | 473.21K | 687.5K | 732.93K | 799.52K | 849.96K | 894.99K | 953.98K | 991.46K | 1.06M | 1.07M | 1.07M | 803.13K | 787.54K | 665.21K | 606.6K | 635.89K | 552.48K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.56M | 0 |
| Total Assets | 10.38M | 14.24M | 14.96M | 2.48M | 4.27M | 5.72M | 7.37M | 10.32M | 6.89M | 4.55M | 7.46M | 12.11M | 16.59M | 21.47M | 25.26M | 31.12M | 36.14M | 40.24M | 4.08M | 4.75M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 143.17% | 148.9% | 102.9% | -75.93% | -38.1% | 25.67% | -1.16% | -14.77% | -58.44% | -78.8% | -70.46% | -61.08% | -54.1% | -46.64% | 519.56% | 554.64% | - | 783.42% | - | - |
| Total Current Liabilities | 7.29M | 13.03M | 13.43M | 13.16M | 12.12M | 6.96M | 7.4M | 10.15M | 11.11M | 11.4M | 10.39M | 11.46M | 11.25M | 12.68M | 18.45M | 17.43M | 18.83M | 16.47M | 80.56M | 67.55M |
| Accounts Payable | 3.39M | 3.43M | 3.69M | 3.31M | 2.66M | 2.73M | 2.36M | 3.2M | 3.49M | 3.91M | 4.28M | 4.89M | 6M | 5.82M | 5.17M | 4.79M | 3.73M | 3M | 1.65M | 2.27M |
| Days Payables Outstanding | 8.51K | 8.49K | 7.38K | 5.58K | 4.78K | 4.35K | 4.09K | 6.75K | 6.25K | 7.03K | 7.89K | 9.54K | 11.65K | 13.33K | 16.12K | 13.69K | 11.17K | 8.96K | 8.88K | - |
| Short-Term Debt | 0 | 5.18M | 5.73M | 5.51M | 5.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 65.42M | 52.53M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.53M | 4.43M | 2.76M | 2.48M | 2.37M | 2.36M | 4.13M | 6.94M | 2.34M | 5.66M | 2.27M | 2.33M | 2.49M | 5.21M | 10.44M | 9.79M | 12.45M | 12.89M | 13.13M | 10.3M |
| Current Ratio | 1.38x | 1.06x | 1.08x | 0.15x | 0.30x | 0.72x | 0.89x | 0.93x | 0.54x | 0.32x | 0.62x | 0.96x | 1.38x | 1.61x | 1.33x | 1.74x | 1.88x | 2.41x | 0.01x | 0.06x |
| Quick Ratio | 1.38x | 1.06x | 1.08x | 0.15x | 0.30x | 0.72x | 0.89x | 0.93x | 0.54x | 0.32x | 0.62x | 0.96x | 1.38x | 1.61x | 1.33x | 1.74x | 1.88x | 2.41x | 0.01x | 0.06x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 15.78M | 15.44M | 15.04M | 14.51M | 13.94M | 18.35M | 17.53M | 16.75M | 16.08M | 11.21M | 10.65M | 10.14M | 9.81M | 9.19M | 58.28K | 0 | 0 | 0 | 27.54K | 383.06K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 4.92M | 4.61M | 4.41M | 4.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 15.78M | 15.44M | 15.04M | 14.51M | 13.94M | 13.42M | 12.92M | 12.35M | 11.87M | 11.21M | 10.65M | 10.14M | 9.81M | 9.19M | 58.28K | 0 | 0 | 0 | 27.54K | 383.06K |
| Total Liabilities | 23.06M | 28.47M | 28.48M | 27.67M | 26.06M | 25.31M | 24.93M | 26.9M | 27.19M | 22.61M | 21.04M | 21.61M | 21.06M | 21.87M | 18.51M | 17.43M | 18.83M | 16.47M | 80.59M | 67.93M |
| Total Debt | 0 | 5.18M | 5.73M | 5.51M | 5.12M | 4.92M | 4.61M | 4.41M | 4.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 65.42M | 52.53M |
| Net Debt | -9.53M | -13.36B | -8.56M | 3.82M | 1.88M | 347.57K | -1.72M | -4.91M | -1.61M | -3.37M | -6.4M | -10.62M | -14.89M | -19.64M | -24.16M | -29.85M | -34.69M | -38.89M | 64.6M | 50.87M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9170.10x | -3726.57x | -15.19x | -6.97x |
| Total Equity | -12.69M | -14.23M | -13.51M | -25.19M | -21.79M | -19.59M | -17.55M | -16.58M | -20.3M | -18.06M | -13.58M | -9.5M | -4.48M | -401.3K | 6.76M | 13.69M | 17.31M | 23.78M | -76.51M | -63.18M |
| Equity Growth % | 41.79% | 27.36% | 23.02% | -51.96% | -7.35% | -8.48% | -29.26% | -74.57% | -353.53% | -4399.21% | -301.01% | -169.36% | -125.86% | -101.69% | 108.83% | 121.67% | - | 144.13% | - | - |
| Book Value per Share | -2.64 | -3.33 | -3.04 | -6.33 | -5.50 | -5.19 | -4.44 | -4.46 | -5.86 | -5.22 | -3.94 | -2.76 | -1.32 | -0.12 | 2.00 | 4.07 | 5.17 | 7.23 | -23.28 | -22.25 |
| Total Shareholders' Equity | -12.69M | -14.23M | -13.51M | -25.19M | -21.79M | -19.59M | -17.55M | -16.58M | -20.3M | -18.06M | -13.58M | -9.5M | -4.48M | -401.3K | 6.76M | 13.69M | 17.31M | 23.78M | -76.51M | -63.18M |
| Common Stock | 51 | 48 | 46 | 40 | 40 | 40 | 395 | 394 | 347 | 346 | 345 | 345 | 343 | 339 | 338 | 337 | 336 | 335 | 242 | 87 |
| Retained Earnings | -159.42M | -156.68M | -154.07M | -151.19M | -146.95M | -144.18M | -141.72M | -139.91M | -137.21M | -133.4M | -127.94M | -122.82M | -116.63M | -110.94M | -103.17M | -96.84M | -90.72M | -82.95M | -77.18M | -62.92M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -697.43K | -718.92K | -692.11K | -719.32K | -662.44K | -631.58K | -672.84K | -611.38K | -385.78K | -430.95K | -313.19K | -401.81K | -373.8K | -292.47K | -78.28K | 1.3M | -102.5K | -625.27K | -789.34K | -1.34M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |